Yasushi Nakai Selected Research

RK 682

5/2020

Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Nakai Research Topics

Disease

45	Neoplasms (Cancer) 06/2022 - 10/2008
38	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 01/2009
26	Urinary Bladder Neoplasms (Bladder Cancer) 06/2021 - 03/2011
21	Carcinoma (Carcinomatosis) 06/2022 - 06/2010
11	Non-Muscle Invasive Bladder Neoplasms 07/2022 - 01/2010
11	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 06/2012
7	Lower Urinary Tract Symptoms 01/2022 - 12/2013
7	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2011
4	Inflammation (Inflammations) 06/2022 - 01/2017
3	Nocturia 07/2022 - 07/2020
3	Urologic Neoplasms (Urological Cancer) 04/2022 - 05/2020
3	Pain (Aches) 01/2021 - 01/2019
3	Adenocarcinoma 12/2020 - 01/2012
2	Polyuria 03/2022 - 07/2020
2	Hypertension (High Blood Pressure) 02/2022 - 02/2016
2	Hypoxia (Hypoxemia) 01/2022 - 03/2011
2	Congenital Abnormalities (Deformity) 01/2022 - 01/2020
2	Cryptorchidism (Undescended Testes) 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2018
2	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 08/2017
2	Hemorrhage 01/2021 - 01/2018
2	Margins of Excision 10/2019 - 06/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2019 - 05/2018
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 09/2022
1	Second Primary Neoplasms (Neoplasms, Second) 09/2022
1	Disease Progression 06/2022
1	Erectile Dysfunction 02/2022
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 01/2022
1	Spinal Dysraphism (Spina Bifida) 01/2022

Drug/Important Bio-Agent (IBA)

14	AcidsIBA 01/2022 - 05/2014
9	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 10/2011
7	Biomarkers (Surrogate Marker)IBA 09/2022 - 05/2014
6	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2016
6	Gemcitabine FDA Link 01/2022 - 06/2010
6	Small Interfering RNA (siRNA)IBA 05/2020 - 01/2010
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2015
5	protoporphyrin IXIBA 01/2022 - 08/2014
4	CytokinesIBA 06/2022 - 01/2017
4	pembrolizumabIBA 03/2022 - 05/2020
4	NitrosaminesIBA 06/2021 - 01/2017
4	AntibodiesIBA 06/2019 - 01/2018
4	Sunitinib (Sutent)FDA Link 10/2018 - 06/2012
4	Heme Oxygenase-1IBA 03/2016 - 01/2010
3	AndrogensIBA 02/2022 - 02/2015
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2020 - 05/2018
3	Docetaxel (Taxotere)FDA Link 03/2020 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2019 - 01/2010
2	CreatinineIBA 07/2022 - 01/2018
2	Claudin-4IBA 06/2022 - 11/2020
2	Biological ProductsIBA 06/2022 - 10/2016
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2022
2	Testosterone (Sustanon)FDA Link 02/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 03/2016
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2022 - 09/2020
2	CarcinogensIBA 06/2021 - 04/2018
2	5-aminolevulinic acid hexyl ester FDA Link 01/2021 - 11/2017
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 10/2020 - 01/2018
2	EnzymesIBA 05/2020 - 01/2018
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2019 - 01/2018
2	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2019 - 05/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2019 - 03/2011
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2019 - 01/2017
2	Iodine-125IBA 01/2019 - 08/2017
2	Flutamide (Eulexin)FDA LinkGeneric 05/2018 - 08/2015
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 03/2011
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2017
2	CollagenIBA 11/2017 - 05/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 06/2012
2	zinc protoporphyrinIBA 03/2011 - 06/2010
1	DNA (Deoxyribonucleic Acid)IBA 06/2022
1	EquolIBA 06/2022
1	IsoflavonesIBA 06/2022
1	daidzeinIBA 06/2022
1	ThuliumIBA 04/2022
1	HolmiumIBA 04/2022
1	SaltsIBA 03/2022
1	choreitoIBA 03/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2022
1	Muscarinic AntagonistsIBA 01/2022
1	PlatinumIBA 01/2022

Therapy/Procedure

19	Brachytherapy 09/2022 - 08/2017
19	Therapeutics 07/2022 - 03/2011
12	Radiotherapy 09/2022 - 01/2015
10	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
9	Nephrectomy 01/2021 - 11/2013
8	Transurethral Resection of Bladder 02/2021 - 01/2015
7	Prostatectomy (Retropubic Prostatectomy) 04/2022 - 01/2009
7	Cystectomy 10/2019 - 01/2016
4	Castration 03/2020 - 05/2018
3	Kidney Transplantation 01/2022 - 01/2018
3	Nephroureterectomy 01/2021 - 05/2019
2	Orchiopexy 01/2022 - 01/2020
2	Oral Administration 06/2021 - 01/2019
2	Operative Time 01/2021 - 02/2019
2	Neoadjuvant Therapy 10/2019 - 04/2018
1	Laser Therapy (Surgery, Laser) 04/2022